Research programme: rare diseases and cancer therapeutics - LAM Therapeutics

Drug Profile

Research programme: rare diseases and cancer therapeutics - LAM Therapeutics

Alternative Names: Anti-cancer therapeutics - LAM Therapeutics; Rare disease therapeutics - LAM Therapeutics

Latest Information Update: 08 Feb 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator LAM Therapeutics
  • Class Antineoplastics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Research Cancer

Most Recent Events

  • 01 Feb 2016 Early research in Cancer in USA (unspecified route) before February 2016 (LAM Therapeutics website, February 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top